Santaris Adds miR-33 to Its Pipeline Via Mass General Licensing Deal

The microRNA has been shown to suppress a protein important for the generation of high-density lipoprotein and for the removal of of cholesterol from peripheral tissues, according to the company.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.